MRC1 and endometrial carcinoma: Given that endometrial carcinoma is often the sentinel malignancy in women with Lynch syndrome, recognition of MMR protein loss at the hyperplasia stage could prompt timely genetic counseling and surveillance strategies, not only for the patient but also for at risk relatives [14].